Literature DB >> 14976268

Managing malignant disease in patients with porphyria.

C Palmieri1, D M Vigushin, T J Peters.   

Abstract

Certain types of porphyria have an increased incidence of malignant disease. In addition, patients with all forms of porphyria may develop malignant disease as a 'normal life event'. The investigation and treatment of porphyric patients with malignant disease requires specific precautions to minimize the risk of an acute porphyric attack, and to ensure optimum treatment of the malignancy. We briefly review the biochemical basis, clinical features and current management of porphyria in cancer patients.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14976268     DOI: 10.1093/qjmed/hch027

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  4 in total

1.  Feline porphyria associated with anemia, severe hepatic disease, and renal calculi.

Authors:  Jonathan J Schnier; Paul Hanna
Journal:  Can Vet J       Date:  2010-10       Impact factor: 1.008

Review 2.  Insights into the pathogenesis and treatment of cancer from inborn errors of metabolism.

Authors:  Ayelet Erez; Oleg A Shchelochkov; Sharon E Plon; Fernando Scaglia; Brendan Lee
Journal:  Am J Hum Genet       Date:  2011-04-08       Impact factor: 11.025

Review 3.  Severe radiation therapy-related soft tissue toxicity in a patient with porphyria cutanea tarda: a literature review.

Authors:  G Brandon Gunn; Karl E Anderson; Abhilasha J Patel; Juan Gallegos; Csilla Kormos Hallberg; Gagan Sood; Sandra S Hatch; Giuseppe Sanguineti
Journal:  Head Neck       Date:  2010-08       Impact factor: 3.147

4.  Methotrexate and actinomycin D chemotherapy in a patient with porphyria: a case report.

Authors:  Yukiko Mikami; Tomonori Nagai; Yousuke Gomi; Yasushi Takai; Masahiro Saito; Kazunori Baba; Hiroyuki Seki
Journal:  J Med Case Rep       Date:  2016-01-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.